Overview

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

Status:
COMPLETED

Trial end date:
2023-12-20

Target enrollment:

Participant gender:

Summary

In this study the investigators compare the parasacral transcutaneous electric nerve stimulation (PTENS) treatment with Darifenacin to improve OAB symptoms in patients infected with HTLV-1.

Phase:

PHASE4

Details

Lead Sponsor:

Hospital Universitrio Professor Edgard Santos

Treatments:

darifenacin